AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine

AstraZeneca ropes in Catalent gene therapy site to produce viral vectors for COVID-19 vaccine
kblankenship
Mon, 08/24/2020 – 08:58